- Home
- COSM
COSM
Cosmos Health Inc.
as 10-29-2025 9:37am EST
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | THESSALONIKI |
| Market Cap: | 32.3M | IPO Year: | 2013 |
| Target Price: | N/A | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.89 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.28 - $1.32 | Next Earning Date: | 11-13-2025 |
| Revenue: | $55,093,442 | Revenue Growth: | -2.41% |
| Revenue Growth (this year): | 28.14% | Revenue Growth (next year): | N/A |
Latest Cosmos Health Inc. News
COSM Breaking Stock News: Dive into COSM Ticker-Specific Updates for Smart Investing
GlobeNewswire
13 days ago
Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire
19 days ago
Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility
GlobeNewswire
a month ago
Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units
GlobeNewswire
2 months ago
Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units
TipRanks
4 months ago
Cosmos Health enters U.S. market with DolCas Biotech agreement
MT Newswires
4 months ago
Cosmos Health to Begin Production in US to Mitigate Tariff Exposure
GlobeNewswire
4 months ago
Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech
GlobeNewswire
5 months ago
RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven
Compare COSM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "COSM Cosmos Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.